LINDA HAWLEY: Open Payments
NPI 1871078584 · SUNNYSIDE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 20 payments from 8 companies in 2025. Trend: 2023 $2,227 · 2024 $116 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $216 |
| Neurocrine BioSciences, Inc. | 4 | $107 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Alkermes, Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: REXULTI, INGREZZA, CAPLYTA, INVEGA SUSTENNA, ARISTADA, The Cologuard Plus Collection Kit, Dexcom G6 Transmitter, TRINTELLIX.
Industry payments across WA — which companies pay providers there.
